NEOGENOMICS INC (NEO)

NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. It operates through the Clinical Services and Pharma Services segments. The Clinical Services segment offers cancer testing services to community-based pathologists, hospitals, academic centers, and oncology groups. The Pharma Services segment focuses on supporting pharmaceutical firms in drug development programs by supporting various clinical trials and research. It also provides testing services in support of its pharmaceutical clients' oncology programs from discovery to commercialization. The company was founded by Michael T. Dent on October 29, 1998 and is headquartered in Fort Myers, FL.

Address

9490 NEOGENOMICS WAY
FORT MYERS, FL 33912

Founded

1998

Number of Employees

2,100

Website

http://www.neogenomics.com

Buyback

Buyback Data 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
$ Amount Purchased
($ in 000s )		 - - - - - - $1,275 $1,080 $1,364 $1,715 $992 $1,285
Average Price - - - - - - $29.60 $49.00 $15.62 $16.48 $14.15 $19.68
# Shares Purchased - - - - - - 43,081 22,042 87,344 104,062 70,097 65,325
Buyback Performance 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 Average
Total Return to Date - - - - - - -45.9% -67.3% 2.4% -2.9% 13.1% -18.7%
S&P 500 Return to Date - - - - - - 74.8% 31.7% 37.3% 31.3% 7.4% 36.5%
Excess Total Return - - - - - - -120.8% -99.0% -34.8% -34.3% 5.7% -55.2%
Quartile Rank
Percentile Rank - - - - - - 10% 7% 49% 34% 67% 29%
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed
STONE WARREN

NEOGENOMICS INC
NovoCure Ltd
BONELLO WILLIAM

NEOGENOMICS INC
KELLY MICHAEL AARON

NEOGENOMICS INC